Community Health Systems, Inc. (CYH)
NYSE: CYH · Real-Time Price · USD
3.350
+0.080 (2.45%)
At close: Jan 22, 2026, 4:00 PM EST
3.300
-0.050 (-1.49%)
After-hours: Jan 22, 2026, 4:49 PM EST
Community Health Systems Market Cap
Community Health Systems has a market cap or net worth of $442.83 million as of January 22, 2026. Its market cap has increased by 3.80% in one year.
Market Cap
442.83M
Enterprise Value
11.56B
1-Year Change
3.80%
Ranking
Category
Stock Price
$3.35
Market Cap Chart
Since June 9, 2000, Community Health Systems's market cap has decreased from $1.02B to $442.83M, a decrease of -56.50%. That is a compound annual growth rate of -3.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 453.00M | 4.81% |
| Dec 31, 2025 | 432.20M | 4.02% |
| Dec 31, 2024 | 415.50M | -2.97% |
| Dec 29, 2023 | 428.20M | -26.43% |
| Dec 30, 2022 | 582.00M | -66.90% |
| Dec 31, 2021 | 1.76B | 97.84% |
| Dec 31, 2020 | 888.80M | 160.11% |
| Dec 31, 2019 | 341.70M | 4.21% |
| Dec 31, 2018 | 327.90M | -32.90% |
| Dec 29, 2017 | 488.70M | -23.10% |
| Dec 30, 2016 | 635.50M | -79.73% |
| Dec 31, 2015 | 3.14B | -50.01% |
| Dec 31, 2014 | 6.27B | 68.18% |
| Dec 31, 2013 | 3.73B | 33.04% |
| Dec 31, 2012 | 2.80B | 75.48% |
| Dec 30, 2011 | 1.60B | -53.81% |
| Dec 31, 2010 | 3.46B | 4.51% |
| Dec 31, 2009 | 3.31B | 143.36% |
| Dec 31, 2008 | 1.36B | -61.41% |
| Dec 31, 2007 | 3.52B | 1.43% |
| Dec 29, 2006 | 3.47B | 2.35% |
| Dec 30, 2005 | 3.39B | 39.54% |
| Dec 31, 2004 | 2.43B | -7.09% |
| Dec 31, 2003 | 2.62B | 28.68% |
| Dec 31, 2002 | 2.03B | -19.77% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |